Abstract
No public abstract is available from the verified source records.
Parikshaa Gupta
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Update on the diagnosis and management of malignant pleural effusions
10.1016/j.rmed.2022.106802 · 2022
Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas
10.3324/haematol.2019.241208 · 2021
Leptomeningeal metastasis: The role of cerebrospinal fluid diagnostics
10.3389/fneur.2019.00839 · 2019
CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies
10.1212/01.wnl.0000261909.28915.83 · 2007
The diagnostic utility of oligoclonal bands in multiple sclerosis: A time-course analysis
10.3390/biomedicines13020440 · 2025
Cancer stem cells: Advances in knowledge and implications for cancer therapy
10.1038/s41392-024-01851-y · 2024
Serous effusions in malignant lymphomas: A review
10.1002/dc.20432 · 2006
Molecular testing on serous effusions
10.1002/dc.24392 · 2021
A narrative review of central nervous system involvement in acute leukemias
10.21037/atm-20-3140 · 2021
Malignancies in pleural, peritoneal, and pericardial effusions
10.5858/arpa.2019-0429-oa · 2020
Flow cytometric immunphenotyping of epithelial cancer cells in effusions - Technical considerations and pitfalls
10.1002/cyto.b.20172 · 2007
Cerebrospinal fluid analysis: Current diagnostic methods in central nervous system infectious diseases
10.1590/0004-282x-anp-2022-s114 · 2022
Flow cytometry in the detection of circulating tumor cells in neoplastic effusions
10.1016/j.cca.2023.117651 · 2024
Molecular profiling of malignant pleural effusions with next generation sequencing (NGS): Evidence that supports its role in cancer management
10.3390/jpm10040206 · 2020
Cytomorphological characterisation of angioimmunoblastic T cell lymphoma: A case–control study
10.1136/jclinpath-2021-207887 · 2023
Lymphoreticular malignancies in serous effusions: Cytomorphologic, flow cytometric and immunocytochemical analysis
10.1002/dc.24729 · 2021
High sensitivity of PD-L1 analysis from pleural effusion in nonsmall cell lung cancer
10.1183/23120541.00787-2020 · 2021
Detection of cancer stem cells from patient samples
10.3390/cells14020148 · 2025
Pleural effusion: Shedding light on pleural disease beyond infection and malignancy
2025
Diagnostic sensitivity of pleural fluid cytology in malignant pleural effusions: Systematic review and meta-analysis
10.1136/thoraxjnl-2021-217959 · 2023
Basic analysis of the cerebrospinal fluid: An important framework for laboratory diagnostics of the impairment of the central nervous system
10.3390/cimb44080251 · 2022
Cerebrospinal fluid and central nervous system cytology
2020
Heterogeneity of cancer stem cell-related marker expression is associated with three-dimensional structures in malignant pleural effusion produced by lung adenocarcinoma
10.1111/cyt.13321 · 2024
Molecular diagnostics in cerebrospinal fluid for the diagnosis of central nervous system infections
10.1128/cmr.00021-24 · 2024
Evaluation of pleural fluid cytology for the diagnosis of malignant pleural effusion: A retrospective cohort study
10.1111/imj.15725 · 2022
Molecular testing on serous effusion: An update
10.25259/cytojournal_55_2020 · 2021
Application of multicolour flow cytometry in the detection of metastatic carcinoma in serous effusions: Special emphasis in atypical cytology
10.1111/cyt.12922 · 2021
What you need to know about: The management of malignant pleural effusion
10.12968/hmed.2024.0311 · 2024
Advances in the diagnosis, evaluation, and management of leptomeningeal disease
10.1093/noajnl/vdab108 · 2021
Metastatic carcinoma in effusions
10.25259/cmas_02_09_2021 · 2022
Immunocytochemistry of effusions: Processing and commonly used immunomarkers
10.25259/cmas_02_15_2021 · 2022
Approach to diagnostic cytopathology of serous effusions
2021
Immunocytochemistry of effusion fluids: Introduction to SCIP approach
10.25259/cmas_02_05_2021 · 2022
Utility and proposed algorithm of CSF flow cytometry in hematologic malignancies
10.1007/s00277-018-3336-3 · 2018
Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma
10.1097/jto.0b013e31824cc46b · 2012
Evaluating infectious, neoplastic, immunological, and degenerative diseases of the central nervous system with cerebrospinal fluid-based next-generation sequencing
10.1007/s40291-021-00513-x · 2021
Improving the diagnosis of leptomeningeal metastases by molecular profiling of cell-free DNA from cerebrospinal fluid
10.1016/j.ejca.2025.115783 · 2025
Minimal residual disease monitoring by flow cytometry
10.1016/s1521-6926(03)00067-7 · 2003
Detection of cancer cells in the cerebrospinal fluid: Current methods and future directions
10.1186/2045-8118-8-14 · 2011
Importance of cytopathologic diagnosis in early cancer diagnosis in resource-constrained countries
10.1200/go.21.00337 · 2022
No additional external references are available.